TYK2和JAK1双重抑制

搜索文档
Roivant Sciences (NasdaqGS:ROIV) Update / Briefing Transcript
2025-09-17 21:02
Roivant Sciences (NasdaqGS:ROIV) Update / Briefing September 17, 2025 08:00 AM ET Company ParticipantsStephanie Lee Griffin - COOMatt Gline - CEO & DirectorBenjamin Zimmer - CEOCorinne Johnson - Vice PresidentPrakhar Agrawal - Managing DirectorEmma Gutstein - Equity Research AssociateConference Call ParticipantsDennis Ding - VP - Equity Research AnalystBrian Cheng - Senior Biotech AnalystYaron Werber - MD & Senior Biotechnology AnalystSam Slutsky - MD & Senior Research AnalystSamantha Semenkow - VP - SMid B ...